Support Resources

TruSight Oncology 500 v2 Documentation

DRAGEN TruSight Oncology 500 Analysis Software Documentation

All versions support TSO 500 v1 assay; versions 2.6.2 and above support TSO 500 v2 assay.

DRAGEN TSO 500 Release Supported Assays User Guides Release Notes Date Posted
v2.6
  • TSO 500
  • TSO 500 HT
  • TSO 500 HRD
  • TSO 500 v2 (v2.6.2 only)
  • Jul 30, 2025
  • Jun 25, 2025
  • Jan 16, 2025
  • Oct 25, 2024

v2.5

 
  • TSO 500
  • TSO 500 HT
  • TSO 500 HRD
  • Jun 25, 2025
  • Dec 16, 2024
  • Mar 27, 2024
  • Nov 8, 2023
  • Nov 8, 2023
v2.1
  • TSO 500
  • TSO 500 HT
  • TSO 500 HRD
  • Jul 25, 2023
  • Feb 17, 2023
  • Mar 2, 2023
v1.1
  • TSO 500
  • TSO 500 HT
  • Aug 29, 2022
  • Apr 28, 2022

TruSight Oncology 500 Analysis Software Documentation

All versions support TSO 500 v1 assay; versions 2.0 and above support TSO 500 v2 assay.

TSO 500 Release Supported Assays User Guides Release Notes Date Posted
v2.4
  • TSO 500
  • TSO 500 HT
  • Dec 17, 2024

v2.3

 
  • TSO 500
  • TSO 500 HT
  • Jun 25, 2025
v2.2
  • TSO 500
  • TSO 500 HT
  • Dec 17, 2024
  • Feb 8, 2021
  • Nov 13, 2020
v2.1
  • TSO 500
  • Sep 11, 2020
v2.0
  • TSO 500
  • Sep 11, 2020
  • Sep 11, 2020
v1
  • TSO 500 (DNA only)
  • Jan 8, 2019
Contact Us
Technical Support
  • techsupport@illumina.com

View All Contacts

Share With Tech Support

Get instructions for sharing your desktop while working with Technical Support.

Share Desktop
Other Support
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.